Psoriasis Clinical Trials

Showing 141-160 of 478 trials

Frequency of Tuberculosis in Psoriasis Patients

NCT06563635

Aim of this study is evaluation of patients receiving TNF inhibitor therapy in terms of tuberculosis at the end of 15 years in a single center.

Psoriasis VulgarisTuberculosis

Bezmialem Vakif University719 participantsStarted May 2023

Istanbul, Turkey (Türkiye)

COMPLETED

Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients

NCT04435730

Aims of the study: 1. Measurement of serum level of Mac 2 binding protein among patients with psoriasis, psoriatic arthritis and subclinical psoriatic arthritis compared with healthy individuals. 2. Evaluation of MSUS findings in patients with PsA and subclinical psoriatic arthritis 3. Evaluation of the role of serum level of Mac 2 binding protein and MSUS in predicting arthritis among psoriatic patients.

Psoriasis

Assiut University180 participantsStarted Oct 2020

Asyut, Egypt

RECRUITINGPHASE3

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

NCT06477237

This is a multicenter, randomized, double-blind, placebo-controlled, phase III clinical study which is designed to determine the efficacy, safety, immunogenicity and pharmacokinetics, and pharmacodynamics of HB0017 Injection in the treatment of moderate to severe plaque psoriasis in adults.

Psoriasis

Huabo Biopharm Co., Ltd.400 participantsStarted Mar 2024

Jiangmen, Guangdong, China • Nanyang, Henan, China • Beijing, China +41 more locations

Frequency of Tuberculosis in Psoriasis Patients

Use of Serum M2BP and MSUS to Predict Arthritis in Psoriatic Patients

Study of Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis

Related Searches

SAPHIR : Assessment of Predictive Factors for Persistence of Treatment After Initiation of Adalimumab With a Biosimilar (Adalimumab Fresenius KaBI or Substitution of Reference Adalimumab With the Fresenius Kabi Adalimumab Biosimilar in Patients With Chronic Inflammatory Diseases

Botox Versus Tacrolimus in Psoriasis Vulgaris

Hand Exercises in Psoriatic Arthritis

Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy

Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy

Biologic Therapy for Generalized Pustular Psoriasis

Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis

Effectiveness of Digital Rehabilitation (SIMPLI.REHAB) in Hand Arthritis

A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea

The Novel Electrolyzed Water Spray Treatment Mild Senile Groin Eczema, Neurodermatitis and Psoriasis

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

Assess the Potential for Adrenal Suppression and Systemic Drug Absorption Following Multiple Dosing With DFD-06

Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects

A Study of LY3471851 in Participants With Psoriasis

Excimer Light in Psoriasis

Therapeutic Drug Monitoring of Risankizumab in Psoriasis Patients (BIOLOPTIM-RIS)